M. Bourassa

发表

Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure

A. Camm, J. Le Heuzey, S. Connolly, 2009 .

Biocompatibility aspects of new stent technology.

J. Tardif, R. Mongrain, R. Mongrain, 1998, Journal of the American College of Cardiology.

Neutrophil accumulation in experimental myocardial infarcts: relation with extent of injury and effect of reperfusion.

P. Chatelain, M. Bourassa, G. Dupras, 1987, Circulation.

Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Aypass Angioplasty Revascularization Investigation (BARI).

R. Califf, R. Frye, R. Bach, 1999, Circulation.

Rhythm control versus rate control for atrial fibrillation and heart failure.

J. Le Heuzey, A. Ducharme, M. Talajic, 2008, The New England journal of medicine.

Angiographic evaluation of the natural history of normal coronary arteries and mild coronary atherosclerosis.

B. Chaitman, M. Bourassa, B. Marchandise, 1978, The American journal of cardiology.

Diagnostic accuracy of exercise ECG lead systems in clinical subsets of women.

B. Chaitman, D. Waters, M. Bourassa, 1982, Circulation.

Natural history and patterns of current practice in heart failure. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators.

S. Yusuf, M. Bourassa, J. Ghali, 1993, Journal of the American College of Cardiology.

One-year follow-up results of the 1985-1986 National Heart, Lung, and Blood Institute's Percutaneous Transluminal Coronary Angioplasty Registry.

D. Faxon, S. Kelsey, K. Detre, 1989, Circulation.

Comparison of coronary artery bypass surgery and medical therapy in patients 65 years of age or older. A nonrandomized study from the Coronary Artery Surgery Study (CASS) registry.

R. Kronmal, B. Gersh, T. Ryan, 1985, The New England journal of medicine.

Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial

P. Poole‐Wilson, S. Pocock, M. Motro, 2004, The Lancet.

The role of antiplatelet agents in modifying the extent of restenosis following percutaneous transluminal coronary angioplasty.

F. Kazim, M. Bourassa, J. Lespérance, 1990, American heart journal.

Report of the Joint ISFC/WHO Task Force on Coronary Angioplasty. The International Society and Federation of Cardiology and the World Health Organization.

T. Ryan, M. Nobuyoshi, S. King, 1988, Circulation.

Coronary Angioplasty

J. Hollman, A. Gratsianski, P. Romaniuk, 2005 .

Interobserver variability in interpreting contrast left ventriculograms (CASS).

T. Ryan, L. Wexler, C. Maynard, 1982, Catheterization and cardiovascular diagnosis.

Aorta to coronary artery saphenous vein grafts. Preoperative angiographic criteria for successful surgery.

M. Bourassa, P. Biron, L. Campeau, 1972, The American journal of cardiology.

Optimal resources for examination of the heart and lungs: cardiac catheterization and radiographic facilities. Examination of the Chest and Cardiovascular System Study Group.

W Grossman, D. Adams, I. Gessner, 1983, Circulation.

Angiographic correlates of lesion relevance and suitability for percutaneous transluminal coronary angioplasty and coronary artery bypass grafting in the Bypass Angioplasty Revascularization Investigation study (BARI).

H. Schaff, M. Bourassa, M. Stadius, 1996, The American journal of cardiology.

Effects of probucol on vascular remodeling after coronary angioplasty. Multivitamins and Protocol Study Group.

S. Nattel, J. Tardif, J. Tardif, 1999, Circulation.

Intravascular radiation therapy in atherosclerotic disease: promises and premises.

R. Mongrain, R. Mongrain, M. Bourassa, 1997, European heart journal.

Evaluation of patients with chest pain and normal coronary angiograms.

M. Bourassa, L. Schwartz, M. Bourassa, 2001, Archives of internal medicine.

Prognostic significance of progression of coronary artery disease.

P Théroux, M. Bourassa, P. Théroux, 1985, The American journal of cardiology.

Noninvasive assessment of aortocoronary bypass graft patency using pulsed Doppler echocardiography.

P Peronneau, M. Bourassa, B. Diebold, 1979, The American journal of cardiology.

The variant form of angina: diagnostic and therapeutic implications.

M. Bourassa, A. Betriu, A. Solignac, 1974, American heart journal.

Role of percutaneous transluminal coronary angioplasty in the treatment of unstable angina. Report from the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty and Coronary Artery Surgery Study Registries.

T. Ryan, D. Faxon, C. McCabe, 1984, The American journal of cardiology.

Programmed ventricular stimulation in survivors of an acute myocardial infarction

Pierre THElROUX, M. Bourassa, David D. Waters, 2005 .

Programmed ventricular stimulation in survivors of an acute myocardial infarction

Pierre THElROUX, M. Bourassa, David D. Waters, 2005 .

Prognostic significance of myocardial ischemia detected by ambulatory electrocardiography, exercise treadmill testing, and electrocardiogram at rest to predict cardiac events by one year (the Asymptomatic Cardiac Ischemia Pilot [ACIP] study)

P. Stone, B. Chaitman, G. Knatterud, 1997, The American journal of cardiology.

Influence of pre-PTCA strategy and initial PTCA result in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI).

A. Jacobs, K. Detre, R. Jones, 1999, Circulation.

Is a strategy of intended incomplete percutaneous transluminal coronary angioplasty revascularization acceptable in nondiabetic patients who are candidates for coronary artery bypass graft surgery? The Bypass Angioplasty Revascularization Investigation (BARI).

A. Jacobs, R. Frye, B. Chaitman, 1999, Journal of the American College of Cardiology.

Atherosclerotic changes in coronary vein grafts six years after operation. Angiographic aspect in 110 patients.

M. Bourassa, L. Campeau, P. Vouhé, 1979, The Journal of thoracic and cardiovascular surgery.